Table 1.

BM subsets expressing Kb following transduction

AntibodyTargetBM cell type% Lineage+* cells% Lin+ cells expressing Kb
M1/70 CD11b, Mac-1 Macrophages, NK cells, granulocytes 67 ± 7 42 ± 8 
RA3-6B2 CD45R, B220 B lineage 18 ± 4 9 ± 4 
CT-CD3 CD3 T-cell receptor 1 ± 1 < 1 
RB6-8C5 Ly-6G (Gr-1) Granulocytes 7 ± 3 49 ± 10 
7/4 Unknown Neutrophils 15 ± 4 45 ± 11 
 Total BM   20 ± 7 
AntibodyTargetBM cell type% Lineage+* cells% Lin+ cells expressing Kb
M1/70 CD11b, Mac-1 Macrophages, NK cells, granulocytes 67 ± 7 42 ± 8 
RA3-6B2 CD45R, B220 B lineage 18 ± 4 9 ± 4 
CT-CD3 CD3 T-cell receptor 1 ± 1 < 1 
RB6-8C5 Ly-6G (Gr-1) Granulocytes 7 ± 3 49 ± 10 
7/4 Unknown Neutrophils 15 ± 4 45 ± 11 
 Total BM   20 ± 7 

Shown are the results of two independent experiments.

*

Percentage of cells in BM expressing the lineage marker.

Percentage of cells expressing the lineage marker that are expressing Kb.

Close Modal

or Create an Account

Close Modal
Close Modal